Key facts
- Wonder Sciences’s last known valuation is $35.0M (Jun 2022).
- It has raised $7.0M; the latest was Later Stage VC in Jan 2025.
- Notable investors include Lionheart Ventures, Aaron Stone, Ambria Capital, Aubrey Marcus, James Foster — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Wonder Sciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Wonder Sciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Wonder Sciences
Operator of an online telemedicine platform intended for mental health and wellness. The company's platform uses psychedelic medicines, novel therapeutic protocols, and revolutionary scientific research capabilities to generate breakthroughs in patients and elevate the consciousness of the planet, enabling patients struggling with depression and anxiety to embark upon a safe, self-healing journey from the comforts of home.
- Sector
- Healthcare
- HQ
- Los Angeles, CA, United States
- Founded
- 2019
- Employees
- 15
- Website
- wondersciences.com/
- Ownership
- Privately Held (backing)
Wonder Sciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Wonder Sciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Wonder Sciences in its N-PORT filings yet. We sweep new filings monthly.